Company Filing History:
Years Active: 2002-2003
Title: H Randall Munson, Jr: Innovator in Pharmaceutical Research
Introduction
H Randall Munson, Jr. is a notable inventor based in Annandale, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit cyclin-dependent kinases. His work has implications for cancer treatment and neuroprotection.
Latest Patents
Munson holds three patents, with his latest inventions focusing on 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines. These compounds are designed to inhibit cyclin-dependent kinases, especially cdk-2. The inventions also provide methods for preventing apoptosis in neuronal cells and inhibiting the development of neoplasms.
Career Highlights
He is currently associated with Aventis Pharmaceuticals Inc., where he continues to innovate in the pharmaceutical sector. His research has been pivotal in advancing therapeutic options for various diseases.
Collaborations
Some of his notable coworkers include Jennifer A Dumont and Alan J Bitonti, who have collaborated with him on various projects within the pharmaceutical industry.
Conclusion
H Randall Munson, Jr. is a distinguished inventor whose work in pharmaceutical research has the potential to impact the treatment of serious health conditions. His contributions to the field are invaluable and continue to inspire future innovations.